Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Lifecore Biomedical, Inc. \De\ (LFCR) Interest Coverage Ratio (2016 - 2024)

Historic Interest Coverage Ratio for Lifecore Biomedical, Inc. \De\ (LFCR) over the last 16 years, with Q4 2024 value amounting to 0.42.

  • Lifecore Biomedical, Inc. \De\'s Interest Coverage Ratio rose 739.2% to 0.42 in Q4 2024 from the same period last year, while for May 2025 it was 1.91, marking a year-over-year decrease of 21688.8%. This contributed to the annual value of 0.6 for FY2024, which is 5231.97% up from last year.
  • Latest data reveals that Lifecore Biomedical, Inc. \De\ reported Interest Coverage Ratio of 0.42 as of Q4 2024, which was up 739.2% from 2.63 recorded in Q3 2024.
  • In the past 5 years, Lifecore Biomedical, Inc. \De\'s Interest Coverage Ratio ranged from a high of 1.33 in Q4 2021 and a low of 6.79 during Q1 2020
  • Its 5-year average for Interest Coverage Ratio is 1.33, with a median of 0.85 in 2021.
  • As far as peak fluctuations go, Lifecore Biomedical, Inc. \De\'s Interest Coverage Ratio tumbled by 930169.18% in 2022, and later surged by 13665.52% in 2024.
  • Over the past 5 years, Lifecore Biomedical, Inc. \De\'s Interest Coverage Ratio (Quarter) stood at 0.86 in 2020, then soared by 54.9% to 1.33 in 2021, then plummeted by 211.23% to 1.48 in 2022, then skyrocketed by 69.15% to 0.46 in 2023, then grew by 7.39% to 0.42 in 2024.
  • Its Interest Coverage Ratio was 0.42 in Q4 2024, compared to 2.63 in Q3 2024 and 0.44 in Q2 2024.